Scientists at the University of Pennsylvania are launching a new program to create adeno-associated virus ( University ) vectors created for gene-editing, these AAVs are used by gene therapies to target the host cells without damaging them. At the moment, experts are working with AAVs developed Earlier this year , but the aim is to "significantly improve their performance" and come up with "therapeutic applications of genome editing". a decade ago , the University partnered with AAV , the the United States 's oldest biotechnology company, to advance gene therapy and gene editing techniques.
Scientists at the University of Pennsylvania are launching a new program to create adeno-associated virus (AAV) vectors created for gene-editing, these AAVs are used by gene therapies to target the host cells without damaging them. At the moment, experts are working with AAVs developed a decade ago, but the aim is to "significantly improve their performance" and come up with "therapeutic applications of genome editing". Earlier this year, the University partnered with Biogen, the US's oldest biotechnology company, to advance gene therapy and gene editing techniques.